In terms of AD pathogenesis, the results of this study may motivate structure guided strategies that target APOE helix 4 and its presentation to receptors (e.g., TREM2), aiming to stabilize favorable conformations or lessen pathological ones. The gene discussed is TREM2; the disease is Alzheimer disease.